Command Palette

Search for a command to run...

Vanta Bioscience Ltd.
22.65(-9.98%)
1W: +3.84%

Vanta Bioscience Key Ratios

Cash Conversion Cycle

Latest:-2109.4 days

Return on Equity

Latest:-52.6%

Return on Capital Employed

Latest:-4.1%

Dupont Analysis

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
ROE4.43%1.89%0.56%-50.31%-52.62%
PAT margin-23.82%-103.26%0.91%4.58%7.30%
Asset Turnover0.32x0.17x0.13x0.08x0.11x
Leverage1.92x2.50x3.15x4.00x5.20x

Efficiency Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Inventory Days300.0432.2320.3418.5275.5
Receivable Days38.161.959.389.995.7
Payable Days146.7213.0761.41287.02480.6
Cash Conversion Cycle191.4281.1-381.8-778.5-2109.4

Return Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
ROE4.43%1.89%0.56%-50.31%-52.62%
ROCE8.62%5.42%4.00%-6.10%-4.08%
ROA2.31%0.76%0.18%-12.57%-10.12%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.